Malignant neoplasm of gastrointestinal tract
ArriVent Expands ADC Pipeline with Exclusive License for MRG007 from Lepu Biopharma
ArriVent BioPharma, Lepu Biopharma, MRG007, Antibody Drug Conjugate (ADC), Gastrointestinal Cancers, Exclusive License Agreement